A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19
Background No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2.
Methods We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection, which causes the respiratory illness Covid-19, and an oxygen saturation (Sao2) of 94% or less while they were breathing ambient air or a ratio of the partial pressure of oxygen (Pao2) to the fracti...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Pubs id:
- Local pid:
- Deposit date:
- Copyright holder:
- Massachusetts Medical Society
- Copyright date:
- Rights statement:
- Copyright © 2020 Massachusetts Medical Society.
If you are the owner of this record, you can report an update to it here: Report update to this record